Docosahexaenoic Acid (DHA) Dietary Supplement

DIETARY_SUPPLEMENT2 trials

Sponsors

National Eye Institute (NEI), Francisco Javier Martínez Noguera

Conditions

Function ImprovementIntervention StudyMacular DegenerationMultiple SclerosisPerformance EnhancementStrength OutcomesSupplemental Nutrition Assistance Program Education

Phase 1

Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy

CompletedNCT00060749

National Eye Institute (NEI)Macular Degeneration

Start: 2003-05-05End: 2007-12-10Target: 22Updated: 2017-07-02

Unknown Phase

Effects of DHA in Patients With Multiple Sclerosis

Enrolling by invitationNCT07346703

Francisco Javier Martínez NogueraFunction Improvement, Intervention Study, Multiple Sclerosis +3

Start: 2026-01-01End: 2026-07-01Target: 100Updated: 2026-01-16

Related Papers

Investigation of the effect of dietary docosahexaenoic acid (DHA) supplementation on macular function in subjects with autosomal recessive Stargardt macular dystrophy.

2018-06-1811 citations